Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4869) 4869
Book Review (592) 592
Publication (417) 417
Conference Proceeding (12) 12
Book Chapter (8) 8
Magazine Article (4) 4
Book / eBook (2) 2
Web Resource (2) 2
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4632) 4632
humans (4191) 4191
oncology (2308) 2308
female (2174) 2174
docetaxel (2082) 2082
taxoids - pharmacology (1757) 1757
male (1748) 1748
pharmacology & pharmacy (1649) 1649
taxoids - administration & dosage (1575) 1575
animals (1439) 1439
chemotherapy (1401) 1401
middle aged (1321) 1321
cell line, tumor (1252) 1252
aged (1215) 1215
cancer (1162) 1162
antineoplastic agents - pharmacology (1122) 1122
paclitaxel (1113) 1113
antineoplastic combined chemotherapy protocols - therapeutic use (1071) 1071
taxoids (1004) 1004
adult (994) 994
taxoids - therapeutic use (960) 960
breast neoplasms - drug therapy (910) 910
mice (881) 881
paclitaxel - analogs & derivatives (765) 765
treatment outcome (702) 702
paclitaxel - pharmacology (603) 603
antineoplastic agents - therapeutic use (599) 599
breast cancer (577) 577
taxoids - chemistry (564) 564
drug resistance, neoplasm (558) 558
apoptosis - drug effects (555) 555
taxoids - adverse effects (537) 537
antineoplastic combined chemotherapy protocols - adverse effects (523) 523
breast neoplasms - pathology (522) 522
apoptosis (507) 507
antineoplastic agents - administration & dosage (501) 501
dose-response relationship, drug (488) 488
prostatic neoplasms - drug therapy (481) 481
antineoplastic agents, phytogenic - pharmacology (475) 475
taxoids - pharmacokinetics (474) 474
lung neoplasms - drug therapy (462) 462
antineoplastic agents (461) 461
medicine & public health (457) 457
prostate cancer (447) 447
therapy (445) 445
research (431) 431
expression (427) 427
antimitotic agents (425) 425
cell proliferation - drug effects (425) 425
analysis (417) 417
care and treatment (416) 416
pharmacology/toxicology (416) 416
taxol (406) 406
drug administration schedule (393) 393
neoplasms - drug therapy (386) 386
antineoplastic agents, phytogenic - therapeutic use (382) 382
paclitaxel - administration & dosage (381) 381
xenograft model antitumor assays (378) 378
breast-cancer (376) 376
cell survival - drug effects (370) 370
in-vitro (370) 370
mice, nude (367) 367
cisplatin (355) 355
chemistry, medicinal (354) 354
carcinoma, non-small-cell lung - drug therapy (348) 348
pharmacokinetics (344) 344
disease-free survival (338) 338
trial (338) 338
metastasis (336) 336
antineoplastic agents - chemistry (335) 335
tumors (332) 332
antineoplastic combined chemotherapy protocols - administration & dosage (330) 330
cancer research (330) 330
carcinoma (329) 329
deoxycytidine - analogs & derivatives (329) 329
aged, 80 and over (328) 328
nanoparticles (326) 326
taxanes (326) 326
neoplasm metastasis (316) 316
prostatic neoplasms - pathology (313) 313
biochemistry & molecular biology (310) 310
antineoplastic combined chemotherapy protocols - pharmacology (308) 308
paclitaxel - therapeutic use (308) 308
doxorubicin (304) 304
drug synergism (301) 301
drug therapy (294) 294
antineoplastic agents - pharmacokinetics (289) 289
tumor cells, cultured (289) 289
cisplatin - administration & dosage (283) 283
drug delivery systems (283) 283
article (269) 269
drugs (266) 266
lung neoplasms - pathology (266) 266
antineoplastic agents, phytogenic - administration & dosage (256) 256
taxotere (254) 254
cells (252) 252
health aspects (250) 250
phase-ii trial (250) 250
survival (246) 246
survival analysis (242) 242
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4727) 4727
Chinese (56) 56
Japanese (52) 52
French (22) 22
German (12) 12
Spanish (4) 4
Italian (3) 3
Polish (2) 2
Russian (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
by Lianne Fuino and Purva Bali and Sylvie Wittmann and Sreenivas Donapaty and Fei Guo and Hirohito Yamaguchi and Hong-Gang Wang and Peter Atadja and Kapil Bhalla
Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2003, Volume 2, Issue 10, pp. 971 - 984
Histone deacetylase inhibitors induce hyperacetylation of the amino-terminal lysine residues of the core nucleosomal histones, which results in chromatin... 
SIGNAL-TRANSDUCTION | ACUTE-LEUKEMIA CELLS | ONCOLOGY | ACETYLATION | RESISTANCE | RECEPTOR | RAF-1 | MONOCLONAL-ANTIBODY | OVARIAN-CANCER | TAXOL-INDUCED APOPTOSIS | HSP90 FUNCTION | Chromatin - metabolism | Phosphorylation | Taxoids - pharmacology | Coloring Agents - pharmacology | Annexin A5 - pharmacology | Humans | Epothilones - pharmacology | Multienzyme Complexes - metabolism | Deoxycytidine - pharmacology | Proteasome Endopeptidase Complex | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Sepharose - pharmacology | Cysteine Endopeptidases - metabolism | Flow Cytometry | Cyclins - metabolism | Time Factors | Antimetabolites, Antineoplastic - pharmacology | Antineoplastic Agents - pharmacology | Hydroxamic Acids - pharmacology | Detergents - pharmacology | Receptor, ErbB-2 - biosynthesis | Cyclin-Dependent Kinase Inhibitor p21 | Antibodies, Monoclonal - pharmacology | Down-Regulation | Enzyme Inhibitors - pharmacology | Tetrazolium Salts - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Blotting, Western | Precipitin Tests | Blotting, Northern | Cell Line, Tumor | Histone Deacetylase Inhibitors | Thiazoles - pharmacology | Antineoplastic Agents, Phytogenic - pharmacology | Deoxycytidine - analogs & derivatives | Microscopy, Fluorescence | Trastuzumab | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rational combinations of Trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer
by Pegram, Mark D and Konecny, Gottfried E and O'Callaghan, Carminda and Beryt, Malgorzata and Pietras, Richard and Slamon, Dennis J
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2004, Volume 96, Issue 10, pp. 739 - 749
Background. Trastuzumab, a humanized anti-HER2 antibody, increases the clinical benefit of first-line chemotherapy in patients with metastatic breast cancers... 
TUMOR-CELL LINES | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | IN-VITRO | PACLITAXEL TAXOL(R) | ONCOLOGY | 1ST-LINE CHEMOTHERAPY | RANDOMIZED-TRIAL | MONOCLONAL-ANTIBODY | CLINICAL PHARMACOKINETICS | DOCETAXEL TAXOTERE(R) | Up-Regulation | Cyclophosphamide - analogs & derivatives | Paclitaxel - pharmacology | Taxoids - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Receptor, ErbB-2 - metabolism | Deoxycytidine - pharmacology | Transplantation, Heterologous | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Female | Gene Expression Regulation, Neoplastic - drug effects | Receptor, ErbB-2 - drug effects | Disease Models, Animal | Floxuridine - pharmacology | Cell Survival - drug effects | Tumor Stem Cell Assay | Proto-Oncogene Proteins - drug effects | Enzyme-Linked Immunosorbent Assay | Antibodies, Monoclonal - pharmacology | Docetaxel | Breast Neoplasms - drug therapy | DNA, Neoplasm - drug effects | Guanine Nucleotide Exchange Factors | Drug Synergism | Animals | Mice, Nude | Cyclophosphamide - pharmacology | Cell Line, Tumor | Mice | Vinblastine - pharmacology | Carboplatin - pharmacology | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology | Trastuzumab | Vinorelbine | Epirubicin - pharmacology | Chemotherapy | Care and treatment | Breast cancer | Research | Health aspects | Drug therapy | Medical treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
by Andrea E. Prota and Katja Bargsten and Didier Zurwerra and Jessica J. Field and José Fernando Díaz and Karl-Heinz Altmann and Michel O. Steinmetz
Science, ISSN 0036-8075, 2/2013, Volume 339, Issue 6119, pp. 587 - 590
Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for... 
Trucks | Taxoids | Molecular structure | Microtubules | REPORTS | Atoms | Ligands | Biochemistry | Molecular mechanisms of action | Epothilones | Crystal structure | ELECTRON CRYSTALLOGRAPHY | BINDING MODE | COMPLEX | ALPHA-BETA-TUBULIN | DIMER | TAXOL | MULTIDISCIPLINARY SCIENCES | RESOLUTION | GDP-TUBULIN | EPOTHILONE-A | Taxoids - chemistry | Tubulin Modulators - chemistry | Taxoids - pharmacology | Protein Structure, Secondary | Epothilones - chemistry | Tubulin Modulators - pharmacology | Epothilones - pharmacology | Crystallography, X-Ray | Antineoplastic Agents - chemistry | Animals | Bridged-Ring Compounds - chemistry | Macrolides - chemistry | Cattle | Microtubules - drug effects | Chickens | Bridged-Ring Compounds - pharmacology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Tubulin - chemistry | Binding Sites | Antimitotic agents | Care and treatment | Drug interactions | Physiological aspects | Research | Antineoplastic agents | Molecular biology | Health aspects | Cancer | Proteins | Chemotherapy | Inhibitor drugs | Index Medicus | Stability | Taxol | Cell division | Assembly | Anticancer properties
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Application of mixture design response surface methodology for combination chemotherapy in PC-3 human prostate cancer cells
by Oblad, Richard and Doughty, Hayden and Lawson, John and Christensen, Merrill and Kenealey, Jason
Molecular Pharmacology, ISSN 0026-895X, 08/2018, Volume 94, Issue 2, pp. 907 - 916
Combining chemotherapeutics to treat malignant tumors has been shown to be effective in preventing drug resistance, tumor recurrence, and reducing tumor size.... 
RESVERATROL | APOPTOSIS | PREDNISONE | MITOXANTRONE | MECHANISM | CABAZITAXEL | PHARMACOLOGY & PHARMACY | TUMOR-CELLS | DRUG-RESISTANCE | DOCETAXEL | PIPERLONGUMINE | Cell Survival - drug effects | Taxoids - pharmacology | Resveratrol - pharmacology | Humans | Male | Models, Statistical | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Docetaxel - pharmacology | Drug Synergism | Dioxolanes - pharmacology | Piperidines - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Flavonoids - pharmacology | Mitoxantrone - pharmacology | Prostatic Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells
by Muthu, Madaswamy S and Kulkarni, Sneha A and Xiong, Jiaqing and Feng, Si-Shen
International Journal of Pharmaceutics, ISSN 0378-5173, 12/2011, Volume 421, Issue 2, pp. 332 - 340
The aim of this work was to develop a drug delivery system of liposomes, which are coated with -alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS), a... 
Cancer nanotechnology | PEGylation | Molecular biomaterials | Nanomedicine | Stealth liposomes | Taxotere | VITRO | Taxotere (R) | CONTROLLED-RELEASE | POLYETHYLENE-GLYCOL SUCCINATE | CHEMOTHERAPY | P-GLYCOPROTEIN | PACLITAXEL | DELIVERY | NANOPARTICLES | BIODEGRADABLE POLYMERS | PHARMACOLOGY & PHARMACY | IN-VIVO EVALUATION | Taxoids - pharmacology | Humans | Vitamin E - analogs & derivatives | Coumarins - chemistry | Polyethylene Glycols - chemistry | Brain Neoplasms | Microscopy, Atomic Force | Antineoplastic Agents - pharmacology | Vitamin E - chemistry | Polyethylene Glycols - pharmacology | Taxoids - chemistry | Cell Survival - drug effects | Microscopy, Electron, Transmission | Antineoplastic Agents - chemistry | Coumarins - pharmacology | Particle Size | Microscopy, Confocal | Liposomes - chemistry | Glioma | Cell Line, Tumor | Absorption - drug effects | Thiazoles - chemistry | Thiazoles - pharmacology | Liposomes - pharmacology | Liposomes - ultrastructure | Vitamin E - pharmacology | Antimitotic agents | Biological products | Antineoplastic agents | Vitamin E | Cancer | Encapsulation | Cell culture | Solvents | Particle size | Brain tumors | Cytotoxicity | Drug delivery | Coatings | Transmission electron microscopy | Polyethylene glycol | Zeta potential | Glioma cells | Liposomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
by Weiszhár, Zsóka and Czúcz, Judit and Révész, Csaba and Rosivall, László and Szebeni, János and Rozsnyay, Zoltán
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 03/2012, Volume 45, Issue 4, pp. 492 - 498
Immunosafety analysis of pharmaceutical surfactants is an important step in understanding the complex mechanisms by which they induce side effects in... 
Nanoimmunosafety | Micelle | Drug carrier | Complement system | Taxane formulation | Infusion hypersensitivity | SC5B-9 | HISTAMINE-RELEASE | INFUSION | FORMULATION | CANCER | PACLITAXEL | MEMBRANE ATTACK COMPLEX | PHARMACOLOGY & PHARMACY | HYPERSENSITIVITY REACTIONS | ANAPHYLACTOID REACTIONS | PHASE-I | Paclitaxel - pharmacology | Polysorbates - pharmacology | Taxoids - pharmacology | Humans | Antineoplastic Agents - pharmacology | Glycerol - pharmacology | Glycerol - analogs & derivatives | Complement Activation - drug effects | Surface-Active Agents - pharmacology | Drugs | Lectins | Thrombin | Drug delivery systems | Surface active agents | Vehicles | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer
by Zhu, Dunwan and Tao, Wei and Zhang, Hongling and Zhang, Linhua and Liu, Gan and Wang, Teng and Zeng, Xiaowei and Mei, Lin
Acta Biomaterialia, ISSN 1742-7061, 01/2016, Volume 30, pp. 144 - 154
imaging and biodistribution analysis of nude mice bearing HepG2 tumors after tail vein injection of free IR-780, or IR-780 loaded TPGS-PLA/NPs or... 
Liver targeting | Dopamine polymerization | Surface modification | Cancer nanotechnology | Galactosylated nanoparticles | Taxoids - pharmacology | Nanoparticles - chemistry | Humans | Vitamin E - analogs & derivatives | Polyethylene Glycols - chemistry | Lactic Acid - pharmacokinetics | Liver Neoplasms, Experimental - metabolism | Carcinoma, Hepatocellular - drug therapy | Polyesters | Indoles - pharmacology | Vitamin E - chemistry | Lactic Acid - pharmacology | Liver Neoplasms, Experimental - pathology | Polyethylene Glycols - pharmacology | Taxoids - chemistry | Lactic Acid - chemistry | Vitamin E - pharmacokinetics | Polyethylene Glycols - pharmacokinetics | Hep G2 Cells | Taxoids - pharmacokinetics | Xenograft Model Antitumor Assays | Animals | Liver Neoplasms, Experimental - drug therapy | Mice, Nude | Carcinoma, Hepatocellular - pathology | Polymers - pharmacokinetics | Polymers - pharmacology | Indoles - pharmacokinetics | Polymers - chemistry | Mice | Drug Delivery Systems - methods | Indoles - chemistry | Carcinoma, Hepatocellular - metabolism | Vitamin E - pharmacology | Drugs | Liver cancer | Drug delivery systems | Docetaxel | Vehicles | Nanoparticles | Polyethylene glycol | Tocopherols | Polymerization | Polyols | Nanotechnology | Index Medicus | Surgical implants | Biomedical materials | In vivo testing | Liver | In vivo tests | Palladium | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs
by Reddy, Joseph A and Dorton, Ryan and Bloomfield, Alicia and Nelson, Melissa and Vetzel, Marilynn and Guan, John and Leamon, Christopher P
Clinical Cancer Research, ISSN 1078-0432, 04/2014, Volume 20, Issue 8, pp. 2104 - 2114
Purpose: When evaluated in patients with ovarian and other cancer, vintafolide (EC145), a potent folate-targeted vinca alkaloid conjugate, displayed a toxicity... 
OVEREXPRESSION | ONCOLOGY | FOLATE RECEPTOR EXPRESSION | PHASE-II | CONJUGATE | TISSUES | INHIBITORS | ANTITUMOR-ACTIVITY | CELL-LINES | CANCER | EPITHELIAL OVARIAN-CARCINOMA | Folic Acid - pharmacology | Paclitaxel - pharmacology | Taxoids - pharmacology | Humans | Antineoplastic Agents - administration & dosage | Folic Acid - administration & dosage | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Neoplasms, Experimental - pathology | Vinca Alkaloids - administration & dosage | Vinca Alkaloids - pharmacology | Camptothecin - administration & dosage | Mice, Inbred DBA | Antineoplastic Agents - pharmacology | Paclitaxel - administration & dosage | Camptothecin - analogs & derivatives | Doxorubicin - administration & dosage | Folic Acid - analogs & derivatives | Topotecan - pharmacology | Carboplatin - administration & dosage | Treatment Outcome | Cisplatin - pharmacology | Neoplasms - drug therapy | Drug Synergism | Xenograft Model Antitumor Assays | Taxoids - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Topotecan - administration & dosage | Cell Proliferation - drug effects | Mice, Inbred BALB C | HeLa Cells | Carboplatin - pharmacology | Neoplasms - pathology | Camptothecin - pharmacology | Neoplasms, Experimental - drug therapy | Doxorubicin - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
by Dalvi, Maithili P and Wang, Lei and Zhong, Rui and Kollipara, Rahul K and Park, Hyunsil and Bayo, Juan and Yenerall, Paul and Zhou, Yunyun and Timmons, Brenda C and Rodriguez-Canales, Jaime and Behrens, Carmen and Mino, Barbara and Villalobos, Pamela and Parra, Edwin R and Suraokar, Milind and Pataer, Apar and Swisher, Stephen G and Kalhor, Neda and Bhanu, Natarajan V and Garcia, Benjamin A and Heymach, John V and Coombes, Kevin and Xie, Yang and Girard, Luc and Gazdar, Adi F and Kittler, Ralf and Wistuba, Ignacio I and Minna, John D and Martinez, Elisabeth D
Cell Reports, ISSN 2211-1247, 05/2017, Volume 19, Issue 8, pp. 1669 - 1684
Although non-small cell lung cancer (NSCLC) patients benefit from standard taxane-platin chemotherapy, many relapse, developing drug resistance. We established... 
lung cancer | histone methylation | taxane-platin chemotherapy | JIB-04 | GSK-J4 | KDM | histone demethylases | demethylase inhibitors | Jumonji demethylases | drug resistance | CELLS | MELANOMA | THERAPY | CHEMOTHERAPY REGIMENS | MECHANISM | GENE-EXPRESSION | LEUKEMIA | MULTIDRUG-RESISTANCE | CELL BIOLOGY | Lung Neoplasms - drug therapy | Transcription, Genetic - drug effects | Taxoids - pharmacology | Benzazepines - adverse effects | Humans | Aminopyridines - adverse effects | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Taxoids - therapeutic use | Hydrazones - adverse effects | Aminopyridines - therapeutic use | Carboplatin - therapeutic use | Hydrazones - therapeutic use | Jumonji Domain-Containing Histone Demethylases - antagonists & inhibitors | Bridged-Ring Compounds - pharmacology | Neoadjuvant Therapy | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Bridged-Ring Compounds - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Enzyme Inhibitors - pharmacology | Benzazepines - pharmacology | Pyrimidines - pharmacology | Enzyme Inhibitors - therapeutic use | Hydrazones - pharmacology | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Animals | Benzazepines - therapeutic use | Pyrimidines - therapeutic use | Aminopyridines - pharmacology | Pyrimidines - adverse effects | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Histones - metabolism | Carboplatin - pharmacology | Methylation | Jumonji Domain-Containing Histone Demethylases - metabolism | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
by Frömberg, Anja and Gutsch, Daniela and Schulze, Daniel and Vollbracht, Claudia and Weiss, Gabriele and Czubayko, Frank and Aigner, Achim
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2011, Volume 67, Issue 5, pp. 1157 - 1166
While the benefits of ascorbic acid (vitamin C, ascorbate) as an essential nutrient are well established, its effects on tumor cells and in tumor treatment are... 
Prostate carcinoma | Medicine & Public Health | Paclitaxel | Cancer Research | Oncology | Ascorbate | Pharmacology/Toxicology | Dehydroascorbate | 5-FU | CANCER-CELLS | APOPTOSIS | DOSE VITAMIN-C | DEHYDROASCORBIC ACID | BREAST-CARCINOMA CELLS | IN-VITRO | MELANOMA | ONCOLOGY | GROWTH | PHARMACOLOGY & PHARMACY | HYDROGEN-PEROXIDE | MODULATION | Cell Survival - drug effects | Taxoids - pharmacology | Apoptosis - drug effects | Humans | Male | Organoplatinum Compounds - pharmacology | Drug Synergism | Prostatic Neoplasms | Vinblastine - analogs & derivatives | Ascorbic Acid - pharmacology | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Dehydroascorbic Acid - pharmacology | Vinblastine - pharmacology | Cell Cycle - drug effects | Camptothecin - pharmacology | Camptothecin - analogs & derivatives | Epirubicin - pharmacology | Drugs | Antimitotic agents | Care and treatment | Anthracyclines | Cell cycle | Drug therapy | Antineoplastic agents | Organic acids | Cancer | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Non‐THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro‐apoptotic effects and underlying mechanisms
by De Petrocellis, Luciano and Ligresti, Alessia and Schiano Moriello, Aniello and Iappelli, Mariagrazia and Verde, Roberta and Stott, Colin G and Cristino, Luigia and Orlando, Pierangelo and Di Marzo, Vincenzo
British Journal of Pharmacology, ISSN 0007-1188, 01/2013, Volume 168, Issue 1, pp. 79 - 102
BACKGROUND AND PURPOSE Cannabinoid receptor activation induces prostate carcinoma cell (PCC) apoptosis, but cannabinoids other than ?9-tetrahydrocannabinol... 
TRP channel | apoptosis | androgen | prostate | cannabinoid | ROS | ACTIVATION | HUMAN BREAST | CANNABIDIOL | ENDOCANNABINOID SYSTEM | PC-3 CELLS | CHANNEL | PHARMACOLOGY & PHARMACY | RECEPTOR POTENTIAL VANILLOID-1 | TUMOR-GROWTH | EXPRESSION | CANCER CELL-LINES | Prostatic Neoplasms - metabolism | Reactive Oxygen Species - metabolism | Taxoids - pharmacology | Nitriles - pharmacology | Apoptosis - drug effects | Humans | Receptors, Androgen - metabolism | Caspase 3 - metabolism | Cell Survival - genetics | Apoptosis - genetics | Male | Prostate - metabolism | Tosyl Compounds - pharmacology | Prostate - pathology | Drug Interactions | Receptors, Androgen - drug effects | Caspase 3 - drug effects | Tumor Cells, Cultured | Dronabinol - pharmacology | Prostatic Neoplasms - drug therapy | Cell Survival - drug effects | Prostatic Neoplasms - pathology | Androgen Antagonists - pharmacology | Cannabidiol - pharmacology | Down-Regulation - drug effects | Cannabinoids - pharmacology | Animals | TRPM Cation Channels - antagonists & inhibitors | Mice, Nude | Transient Receptor Potential Channels - drug effects | Anilides - pharmacology | Mice | Cell Cycle - drug effects | Enzymes | Starvation | Carcinoma | Growth | Genes | Fluorescence | Gene expression | Estradiol | Cannabinoids | Anopheles | Messenger RNA | DNA | Phenols | Marijuana | Tumor proteins | Prostate cancer | Cancer | Index Medicus | Research Papers with Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
by Tamaki, Hiroki and Harashima, Nanae and Hiraki, Miho and Arichi, Naoko and Nishimura, Nobuhiro and Shiina, Hiroaki and Naora, Kohji and Harada, Mamoru
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 22, pp. 11399 - 11412
Docetaxel (DTX) is a useful chemotherapeutic drug for the treatment of hormone-refractory prostate cancer. However, emergence of DTX resistance has been a... 
Bcl-2 | Bcl-xL | Prostate cancer | Docetaxel | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
by Liu, P and Kumar, I.S and Brown, S and Kannappan, V and Tawari, P.E and Tang, J.Z and Jiang, W and Armesilla, A.L and Darling, J.L and Wang, W
British Journal of Cancer, ISSN 0007-0920, 10/2013, Volume 109, Issue 7, pp. 1876 - 1885
Background: Triple-negative breast cancer (TNBC) has significantly worse prognosis. Acquired chemoresistance remains the major cause of therapeutic failure of... 
paclitaxel | breast cancer | disulfiram | acquired resistance | CSCs | 5-FLUOROURACIL | GLIOBLASTOMA | INHIBITION | CISPLATIN | ONCOLOGY | SELF-RENEWAL | INDUCE APOPTOSIS | DRUG-RESISTANCE | MULTIDRUG-RESISTANCE | EXPRESSION | KAPPA-B ACTIVITY | Receptors, Estrogen - metabolism | Paclitaxel - pharmacology | Taxoids - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Enzyme Inhibitors - pharmacology | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Receptors, Progesterone - metabolism | Receptor, Epidermal Growth Factor - metabolism | Cell Line, Tumor | Female | Cell Proliferation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Disulfiram - pharmacology | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects | Index Medicus | Molecular Diagnostics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights